Suppr超能文献

用于口服给药的脂质载体。

Lipid-based vehicle for oral drug delivery.

作者信息

Stuchlík M, Zák S

机构信息

Research, Development and Clinical Department, IVAX-CR a.s., Ostravská 29, 747 70 Opava 9, Czech Republic.

出版信息

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2001 Dec;145(2):17-26.

Abstract

With an increasing number of lipophilic drugs under development, homolipids and heterolipids have gained renewed interests as excipients for oral drug delivery systems. Oral administration has many advantages for chronic drug therapy. It is relatively safe, convenient for the patient and allows self administration. This article is not intended to review the broad area of lipid-based vehicle for oral drug delivery comprehensively. The rationale behind choosing lipids materials for pharmaceutical dosage forms and their applications is discussed. It also comments on the methods for monitoring the physicochemical properties of vehicles and formulations and describes a range of pharmacopoeial excipients suitable for these purposes. The excipients selected here are pharmacopoeial in European Pharmacopoeia 4th Ed., United States Pharmacopoeia 24th Ed./National Formulary 19th Ed. and Japanese Pharmacopoeia 13th Ed. or are drafted in Pharmaeuropa and Pharmacopoeial Forum. Widening availability of lipidic excipients with specific characteristics offer flexibility of application with respect to improving the bioavailability of poorly water-soluble drugs and manipulating release profiles.

摘要

随着越来越多的亲脂性药物处于研发阶段,同脂质和异脂质作为口服给药系统的辅料重新引起了人们的关注。口服给药对于慢性药物治疗具有诸多优势。它相对安全,对患者方便且允许自我给药。本文并非旨在全面综述基于脂质的口服给药载体这一广泛领域。讨论了选择脂质材料用于药物剂型的基本原理及其应用。还对监测载体和制剂物理化学性质的方法进行了评论,并描述了一系列适用于这些目的的药典辅料。此处所选的辅料在《欧洲药典》第4版、《美国药典》第24版/《国家处方集》第19版和《日本药典》第13版中是药典收载的,或者是在《欧洲制药杂志》和《药典论坛》中起草的。具有特定特性的脂质辅料可用性的拓宽,在提高难溶性药物的生物利用度和控制释放曲线方面提供了应用灵活性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验